Journey Medical Corporation (NASDAQ: DERM)
$6.05
+0.1400 ( +2.37% ) 46.4K
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Market Data
Open
$6.05
Previous close
$5.91
Volume
46.4K
Market cap
$116.28M
Day range
$5.79 - $6.10
52 week range
$1.60 - $8.11
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | May 01, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
10-k | Annual reports | 106 | Mar 29, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |
4 | Insider transactions | 1 | Feb 23, 2024 |
8-k | 8K-related | 14 | Jan 02, 2024 |